ArQule Articles

Daiichi Sankyo returns rights to ArQule for global AKT program

3 April 2013

Another disappointment with Daiichi Sankyo and ArQule's tivantinib

14 January 2013

ArQule and Daiichi Sankyo drop tivantinib trial in NSCLC

3 October 2012

Daiichi Sankyo to license ARQ 092 from ArQule, under joint AKIP research collaboration

11 November 2011

Kyowa Hakko Kirin starts Ph III trial of ARQ 197 (tivantinib) in NSCLC patients in Asia

10 August 2011

Daiichi Sankyo launches flu drug Inavir inhaler in Japan; expands deal with ArQule; gets favorable patent ruling against Lupin

20 October 2010

ArQule and Daiichi Sankyo move NSCLC drug ARQ 197 into Phase III clinical trial plan

4 August 2010

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end